{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:29:05Z","timestamp":1755800945288,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","interventional.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.iccl.2024.08.012","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T06:22:02Z","timestamp":1728541322000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual Antiplatelet and Anticoagulation Regimens for Women Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"14","author":[{"given":"Aman","family":"Kansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Swamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Rymer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.iccl.2024.08.012_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2020.01.056","article-title":"Long-term outcomes in women and men following percutaneous coronary intervention","volume":"75","author":"Kosmidou","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.iccl.2024.08.012_bib2","doi-asserted-by":"crossref","DOI":"10.1159\/000529863","article-title":"Sex-related bleeding risk in acute coronary syndrome patients receiving dual antiplatelet therapy with aspirin and a P2Y12 inhibitor","volume":"32","author":"Ten Haaf","year":"2023","journal-title":"Med Princ Pract"},{"issue":"7","key":"10.1016\/j.iccl.2024.08.012_bib3","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.iccl.2024.08.012_bib4","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American college of cardiology\/American heart association joint committee on clinical Practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.iccl.2024.08.012_bib5","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.iccl.2024.08.012_bib6","article-title":"A\u00a0new strategy for discontinuation of dual antiplatelet therapy: the reset trial (real safety and efficacy of 3-month dual antiplatelet therapy following endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.iccl.2024.08.012_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-021-02439-x","article-title":"Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial","volume":"52","author":"Verdoia","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"11","key":"10.1016\/j.iccl.2024.08.012_bib8","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-19-00539","article-title":"Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)","volume":"15","author":"de Luca","year":"2019","journal-title":"EuroIntervention"},{"issue":"24","key":"10.1016\/j.iccl.2024.08.012_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.8146","article-title":"Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial","volume":"321","author":"Hahn","year":"2019","journal-title":"JAMA, J Am Med Assoc"},{"issue":"23","key":"10.1016\/j.iccl.2024.08.012_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA, J Am Med Assoc"},{"issue":"5","key":"10.1016\/j.iccl.2024.08.012_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.112.108290","article-title":"Women, bleeding, and coronary intervention","volume":"127","author":"Ahmed","year":"2013","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.iccl.2024.08.012_bib12","article-title":"Sex-related differences in patients at high bleeding risk undergoing percutaneous coronary intervention: a patient-level pooled analysis from 4 postapproval studies","volume":"9","author":"Chandiramani","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"17","key":"10.1016\/j.iccl.2024.08.012_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcin.2021.07.016","article-title":"3- or 1-month DAPT in patients at high bleeding risk undergoing everolimus-eluting stent implantation","volume":"14","author":"Mehran","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.iccl.2024.08.012_bib14","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iccl.2024.08.012_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2023.4316","article-title":"Abbreviated or standard dual antiplatelet therapy by sex in patients at high bleeding risk: a prespecified secondary analysis of a randomized clinical trial","volume":"9","author":"Landi","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2024.08.012_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.050438","article-title":"Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective: 2021 update","volume":"143","author":"Angiolillo","year":"2021","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.iccl.2024.08.012_bib17","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.iccl.2024.08.012_bib18","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.iccl.2024.08.012_bib19","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.iccl.2024.08.012_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2014.10.095","article-title":"Sex differences of leukocyte-platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis","volume":"237","author":"Gremmel","year":"2014","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.iccl.2024.08.012_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/MBC.0b013e32835824b3","article-title":"Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy","volume":"23","author":"Bobbert","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"10","key":"10.1016\/j.iccl.2024.08.012_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association task force on clinical Practice guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.iccl.2024.08.012_bib23","article-title":"Utility of the dual antiplatelet therapy score to guide antiplatelet therapy: a systematic review and meta-analysis","volume":"97","author":"Mihatov","year":"2021","journal-title":"Cathet Cardiovasc Interv"},{"issue":"23","key":"10.1016\/j.iccl.2024.08.012_bib24","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 Months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"40","key":"10.1016\/j.iccl.2024.08.012_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu318","article-title":"Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial","volume":"35","author":"Wijns","year":"2014","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.iccl.2024.08.012_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"J\u00a0Am Med Assoc"},{"issue":"21","key":"10.1016\/j.iccl.2024.08.012_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2009.05.074","article-title":"The relative efficacy and safety of clopidogrel in women and men. A sex-specific collaborative meta-analysis","volume":"54","author":"Berger","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.iccl.2024.08.012_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv038","volume":"36","author":"Costa","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.iccl.2024.08.012_bib29","article-title":"Sex-based differences in bleeding risk after percutaneous coronary intervention and implications for the academic research consortium high bleeding risk criteria","volume":"10","author":"Spirito","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"25","key":"10.1016\/j.iccl.2024.08.012_bib30","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"10206","key":"10.1016\/j.iccl.2024.08.012_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.iccl.2024.08.012_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"Kumbhani","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.iccl.2024.08.012_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2015.02.050","article-title":"Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial","volume":"65","author":"Fiedler","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.iccl.2024.08.012_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical Practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2024.08.012_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2018.07.083","article-title":"Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: an updated meta-analysis","volume":"269","author":"Cardoso","year":"2018","journal-title":"Int J Cardiol"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824000956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824000956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:00:17Z","timestamp":1755694817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745824000956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2211745824000956"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2024.08.012","relation":{},"ISSN":["2211-7458"],"issn-type":[{"type":"print","value":"2211-7458"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual Antiplatelet and Anticoagulation Regimens for Women Undergoing Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2024.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}